A novel nonnucleoside analogue that inhibits human immunodeficiency virus type 1 isolates resistant to current nonnucleoside reverse transcriptase inhibitors.
about
Selective killing of human immunodeficiency virus infected cells by non-nucleoside reverse transcriptase inhibitor-induced activation of HIV protease.Human immunodeficiency virus type 1 resistance or cross-resistance to nonnucleoside reverse transcriptase inhibitors currently under development as microbicides.Connection domain mutations in HIV-1 reverse transcriptase do not impact etravirine susceptibility and virologic responses to etravirine-containing regimensThe HEPT Analogue WPR-6 Is Active against a Broad Spectrum of Nonnucleoside Reverse Transcriptase Drug-Resistant HIV-1 Strains of Different Serotypes.Conformational Plasticity of the NNRTI-Binding Pocket in HIV-1 Reverse Transcriptase: A Fluorine Nuclear Magnetic Resonance Study.Rilpivirine resistance mutation E138K in HIV-1 reverse transcriptase predisposed by prevalent polymorphic mutations.In vitro selection of HIV-1 CRF08_BC variants resistant to reverse transcriptase inhibitors.Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing.Computational development of rubromycin-based lead compounds for HIV-1 reverse transcriptase inhibition.Arylazolyl(azinyl)thioacetanilide. Part 9: Synthesis and biological investigation of thiazolylthioacetamides derivatives as a novel class of potential antiviral agents.Emerging antiviral drugs
P2860
Q34282609-9C192EAA-8900-4CF6-9926-0607951218AEQ34737547-870C2F87-CA3C-4627-BDF4-DAD70AE60592Q35004847-AD88515B-E2AA-4828-9CF0-10EA9AF152C3Q35859896-A7438EFB-C29A-4EA4-90E4-ABDCBAD15BCAQ37114525-23C8D63C-BB7A-43C7-B1C1-E0D173AAECB3Q40688534-DA99E211-71B0-4C20-8214-7022BE3182B3Q41720036-6BB5A91B-D2CD-4091-9C3D-BF1F129A2847Q42101552-56822217-1F42-4D9A-996F-0EA0385C7B23Q42739347-132DA554-7362-48A6-8B42-5CC01E5196EBQ50551450-F49EC323-E1AD-4844-9EB3-A732C21F3F88Q56786308-52A2CB21-9C3A-48C6-938A-64C65D6A8E63
P2860
A novel nonnucleoside analogue that inhibits human immunodeficiency virus type 1 isolates resistant to current nonnucleoside reverse transcriptase inhibitors.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
A novel nonnucleoside analogue ...... erse transcriptase inhibitors.
@en
type
label
A novel nonnucleoside analogue ...... erse transcriptase inhibitors.
@en
prefLabel
A novel nonnucleoside analogue ...... erse transcriptase inhibitors.
@en
P2093
P2860
P356
P1476
A novel nonnucleoside analogue ...... erse transcriptase inhibitors.
@en
P2093
Jae Hoon Shim
Jean-Luc Girardet
Li-Tain Yeh
Robert K Hamatake
Yung-Hyo Koh
Zhijun Zhang
P2860
P304
P356
10.1128/AAC.01032-06
P407
P577
2006-11-20T00:00:00Z